Skip to main content

Table 1 Comparison of clinical data between the LNM and non-LNM groups

From: Histogram analysis based on multi-parameter MR imaging as a biomarker to predict lymph node metastasis in T3 stage rectal cancer

Clinical parameters

LNM

Non-LNM

p value

Sex

 Male

37 (59.7%)

76 (67.3%)

0.316

 Female

25 (40.3%)

37 (32.7%)

 

Age (year)

58.86 ± 10.52

62.09 ± 10.72

0.056

Height (cm)

165.50 (160.0–174.25)

168.0 (162.0–172.0)

0.880

Weight (kg)

66.50‍ (59.75–72.0)

65.0‍ (59.0–73.0)

0.851

Smoking

 No

38 ‍(61.3%)

63 ‍(55.8%)

0.478

 Yes

24 ‍(38.7%)

50 ‍(44.2%)

 

Alcohol

 No

40‍ (64.5%)

74 ‍(65.5%)

0.897

 Yes

22 ‍(35.5%)

39‍ (34.5%)

 

CEA

 < 5 ng/mL

31 ‍(51.7%)

73‍ (65.2%)

0.084

 ≥ 5 ng/mL

29‍ (48.3%)

39 ‍(34.8%)

 

CA199

 < 37 U/mL

50 ‍(84.7%)

106 ‍(96.4%)

0.007

 ≥ 37 U/mL

9‍ (15.3%)

4‍ (3.6%)

 

CA724

 < 6 U/mL

42 ‍(80.8%)

73‍ (85.9%)

0.429

 ≥ 6 U/mL

10 ‍(19.2%)

12 ‍(14.1%)

 

AFP

   

 < 25 ng/mL

30 ‍(100.0%)

61‍ (96.8%)

0.324

 ≥ 25 ng/mL

0

2‍ (3.2%)

 

Histologic grades

 Poor

1 (1.7%)

2 (1.8%)

0.914

 Moderate

58 (96.6%)

107 (95.5%)

 

 Well

1 (1.7%)

3 (2.7%)

 
  1. Continuous variables are presented as mean ± standard deviation. Categorical variables are presented as n (%)
  2. LNM, lymph node metastasis; CEA, carcinoembryonic antigen; CA199, carbohydrate antigen 199; CA724, carbohydrate antigen 724; AFP, alpha-fetoprotein; p < 0.05 are shown in bold